Comerica Bank’s Avita Medical RCEL Stock Holding History

Comerica Bank’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-201	Closed	-$1.06K	–	3793
2025 Q2	$1.06K	Buy	+201	New	+$1.46K	﹤0.01%	3578

Other funds holding RCEL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Comerica Bank's RCEL Position: Q3 2025 in Review

Comerica Bank sold out of Avita Medical (RCEL) in Q3 2025, closing a stake of 201 shares — an estimated $1.06K sold.

Comerica Bank first reported a position in RCEL in Q2 2025 and held it in 1 quarter. The position peaked at $1.06K in Q2 2025. 76 funds tracked by Wall St. Rank hold RCEL as of Q3 2025.

Comerica Bank reported no remaining Avita Medical position as of Q3 2025 after selling out during the quarter.
Comerica Bank sold 201 Avita Medical shares in Q3 2025, an estimated $1.06K.
Comerica Bank first reported a position in Avita Medical in Q2 2025 and held it in 1 quarter.
Comerica Bank's Avita Medical position peaked at $1.06K in Q2 2025.
76 funds tracked by Wall St. Rank held Avita Medical as of Q3 2025.

Based on Comerica Bank's 13F filing for Q3 2025, filed 14 Nov 2025.